Loading...

Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection

Rabbit anti-thymocyte globulin (rATG) is currently the treatment of choice for glucocorticoid-resistant, recurrent, or severe acute allograft rejection (AR). However, rATG is associated with severe infusion-related side effects. Alemtuzumab is incidentally given to kidney transplant recipients as tr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Immunol
Main Authors: van der Zwan, Marieke, Clahsen-Van Groningen, Marian C., van den Hoogen, Martijn W. F., Kho, Marcia M. L., Roodnat, Joke I., Mauff, Katya A. L., Roelen, Dave L., van Agteren, Madelon, Baan, Carla C., Hesselink, Dennis A.
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350932/
https://ncbi.nlm.nih.gov/pubmed/32719676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01332
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!